InvestorsHub Logo
Followers 7
Posts 289
Boards Moderated 0
Alias Born 12/11/2013

Re: rr50 post# 174536

Wednesday, 03/08/2017 1:01:45 PM

Wednesday, March 08, 2017 1:01:45 PM

Post# of 403017
I like the comparison to Mongersen. Similar UP results and after phase 2 got $710 million upfront and $1.9 billion in development milestones!!


http://www.fiercebiotech.com/partnering/celgene-s-2-6b-deal-for-crohn-s-drug-pays-off-promising-phii


Note that Scott Smith leads Celgene's inflammation and immunology group....maybe that explains his posts on this board :)
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News